People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AnchorTherapeutics, Inc | — | Other | Series B | $24.0M | $83.1M | 2010 |
Frederick Jones, III, M.D., MBA at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frederick Jones, III, M.D., MBA on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jens Eckstein | 1 | 8 |
| Michael Webb | 1 | 6 |
| Christopher K. Mirabelli | 1 | 4 |
| LAUREN SILVERMAN | 1 | 3 |
| Frederick Jones | 1 | 2 |
| Michael K Webb | 1 | 2 |
| Thomas McMurry | 1 | 1 |
| Athan Kuliopulos | 1 | 1 |
| Stephen Hunt | 1 | 1 |
| Robert K. Kamen | 1 | 1 |
| Stephen K. Hunt | 1 | 1 |
| Thomas K. McMurry | 1 | 1 |
| Jnes Eckstein | 1 | 1 |
| Lauren K. Silverman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.